Pharmacological treatment for pain in Guillain-Barré syndrome
- 11 July 2012
- reference entry
- Published by Wiley
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or VaccinationClinical Reviews in Allergy & Immunology, 2010
- Gabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS SynaptogenesisCell, 2009
- The Epidemiology of Guillain-Barré Syndrome WorldwideNeuroepidemiology, 2008
- Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT RecommendationsThe Journal of Pain, 2008
- Guillain-Barré syndromeThe Lancet, 2005
- Impairment in Guillain–Barré syndrome during the first 2 years after onset: a prospective studyJournal of the Neurological Sciences, 2004
- Pain in Guillain-Barre syndromeNeurology, 1997
- Opioid Analgesics and the Burning Pain of Guillain-Barré SyndromeAnesthesiology, 1991
- Cabsaicin for the trunent of pain in Guillain‐Barré syndromeAnnals of Neurology, 1990
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990